<code id='DBA84DEB10'></code><style id='DBA84DEB10'></style>
    • <acronym id='DBA84DEB10'></acronym>
      <center id='DBA84DEB10'><center id='DBA84DEB10'><tfoot id='DBA84DEB10'></tfoot></center><abbr id='DBA84DEB10'><dir id='DBA84DEB10'><tfoot id='DBA84DEB10'></tfoot><noframes id='DBA84DEB10'>

    • <optgroup id='DBA84DEB10'><strike id='DBA84DEB10'><sup id='DBA84DEB10'></sup></strike><code id='DBA84DEB10'></code></optgroup>
        1. <b id='DBA84DEB10'><label id='DBA84DEB10'><select id='DBA84DEB10'><dt id='DBA84DEB10'><span id='DBA84DEB10'></span></dt></select></label></b><u id='DBA84DEB10'></u>
          <i id='DBA84DEB10'><strike id='DBA84DEB10'><tt id='DBA84DEB10'><pre id='DBA84DEB10'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:4
          Trump Campaign Event In Nevada
          Ethan Miller/Getty Images

          WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

          In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

          advertisement

          “Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          The strategy behind pharma's lawsuits over drug pricing reform
          The strategy behind pharma's lawsuits over drug pricing reform

          Legalexpertsunpackedthepharmaceuticalindustry'sscattershotapproachtochallengingMedicare'snewpowerton

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

          BristolCEOChristopherBoernerBusinessWireviaAPSANFRANCISCO— ChristopherBoernerhasbeentheCEOofBristolM